Hansen, Emma, Grimm, Daniela, Wehland, Markus (2022) Current Knowledge about the New Drug Firibastat in Arterial Hypertension. International Journal of Molecular Sciences, 23 (3) 1459pp. doi:10.3390/ijms23031459
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Current Knowledge about the New Drug Firibastat in Arterial Hypertension | ||
Journal | International Journal of Molecular Sciences | ||
Authors | Hansen, Emma | Author | |
Grimm, Daniela | Author | ||
Wehland, Markus | Author | ||
Year | 2022 (January 27) | Volume | 23 |
Issue | 3 | ||
Publisher | MDPI AG | ||
DOI | doi:10.3390/ijms23031459Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13702513 | Long-form Identifier | mindat:1:5:13702513:0 |
GUID | 0 | ||
Full Reference | Hansen, Emma, Grimm, Daniela, Wehland, Markus (2022) Current Knowledge about the New Drug Firibastat in Arterial Hypertension. International Journal of Molecular Sciences, 23 (3) 1459pp. doi:10.3390/ijms23031459 | ||
Plain Text | Hansen, Emma, Grimm, Daniela, Wehland, Markus (2022) Current Knowledge about the New Drug Firibastat in Arterial Hypertension. International Journal of Molecular Sciences, 23 (3) 1459pp. doi:10.3390/ijms23031459 | ||
In | (2022, February) International Journal of Molecular Sciences Vol. 23 (3) MDPI AG |
See Also
These are possibly similar items as determined by title/reference text matching only.